InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| IFNL1 | IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. | 2014 | PLoS Pathog. | Egli A. et al. | DOI: 10.1371/journal.ppat.1004556 |
| ODN 1826 VacciGrade™ | Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel The... | 2015 | Mol Ther Nucleic Acids | Prodeus A. et al. | DOI: 10.1038/mtna.2015.11 |
| PlasmoTest™ - Mycoplasma Detection Kit | One cisplatin dose provides durable stimulation of anti-tumor immunity and al... | 2022 | Oncoimmunology | Steenbrugge J. et al. | DOI: 10.1080/2162402X.2022.2103277 |
| Recombinant anti-mouse PD-1 antibody - Clone RMP1-14 (D265A) | One cisplatin dose provides durable stimulation of anti-tumor immunity and al... | 2022 | Oncoimmunology | Steenbrugge J. et al. | DOI: 10.1080/2162402X.2022.2103277 |
| Recombinant anti-mouse CTLA4 antibody | Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces com... | 2023 | J Exp Clin Cancer Res. | Skeltved N. et al. | DOI: 10.1186/s13046-023-02655-8 |
| ODN 1668 - TLR9 ligand | Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces com... | 2023 | J Exp Clin Cancer Res. | Skeltved N. et al. | DOI: 10.1186/s13046-023-02655-8 |
| Recombinant anti-PD-L1 antibodies (D265A) - InvivoFit™ | MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of An... | 2023 | Cancers (Basel) | Magkouta S.F. et al. | DOI: 10.3390/cancers15204962 |
| Recombinant mouse IgG1e3 isotype control - D265A | MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of An... | 2023 | Cancers (Basel) | Magkouta S.F. et al. | DOI: 10.3390/cancers15204962 |
| Anti-β-Gal-hIgG1 (N298A) | Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dep... | 2023 | Acta Pharm Sin B. | Tan J. et al. | DOI: 10.1016/j.apsb.2022.08.006 |
| Recombinant anti-PD-L1 antibodies (D265A) - InvivoFit™ | Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dep... | 2023 | Acta Pharm Sin B. | Tan J. et al. | DOI: 10.1016/j.apsb.2022.08.006 |
| HEK-Blue™ mNOD1 | NOD1 deficiency ameliorates the progression of diabetic retinopathy by modula... | 2024 | Stem Cell Res Ther. | Qiu J. et al. | DOI: 10.1186/s13287-024-03654-y |
| HEK-Blue™ Detection | NOD1 deficiency ameliorates the progression of diabetic retinopathy by modula... | 2024 | Stem Cell Res Ther. | Qiu J. et al. | DOI: 10.1186/s13287-024-03654-y |
| G418 (Geneticin) | Rapid generation of an RBL cellular model to study proteins that cause allerg... | 2024 | Immunol Res. | Hernández-Aguilar I. et al. | DOI: 10.1007/s12026-024-09461-0 |
| QUANTI-Blue™ | Molecular and functional characterization of a type-1 cystatin in amphioxus (... | 2024 | Fish Shellfish Immunol. | Du R. et al. | DOI: 10.1016/j.fsi.2024.109423 |
| Normocin™ - Antimicrobial Reagent | Protocol for neurogenin-2-mediated induction of human stem cell-derived neura... | 2024 | STAR Protoc. | Guss E.J. et al. | DOI: 10.1016/j.xpro.2024.102878 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Cysteine-binding adjuvant enhances survival and promotes immune function in a... | 2024 | Blood Adv. | Slezak A.J. et al. | DOI: 10.1182/bloodadvances.2023012529 |
| Pam3CSK4 | Maclurin inhibits caspase-11 non-canonical inflammasome in macrophages and am... | 2024 | Int Immunopharmacol. | Joon Lee D. et al. | DOI: 10.1016/j.intimp.2024.111615 |
| LPS-PG (Lipopolysaccharide from P. gingivalis) | Oral infection with Porphyromonas gingivalis augmented gingival epithelial ba... | 2024 | J Oral Biosci. | Giri S. et al. | DOI: 10.1016/j.job.2024.01.012 |
| Mouse Control IgG1 | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |
| THP1-Dual™ Cells | The role of extracellular vesicle fusion with target cells in triggering syst... | 2024 | Nat Commun. | Papareddy P. et al. | DOI: 10.1038/s41467-024-45125-1 |